By Adam Feuerstein | Published: Jul 07, 2026
The Food and Drug Administration on Tuesday approved a new medicine from the biotech company Vera Therapeutics for patients with a type of chronic autoimmune kidney disease. The drug, called Trutakn⦠[+607 chars]
Read Full Article